The cellular and molecular carcinogenic effects of radon exposure: A review

International Journal of Molecular Sciences

Volumn 14, Issue 7, 2013, Pages 14024-14063

  Robertson, Aaron ^a   Allen, James ^a   Laney, Robin ^b   Curnow, Alison ^a  

^a UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^b ROYAL CORNWALL HOSPITAL   (United Kingdom)

Author keywords

Alpha particles; Bystander effect; Carcinogenesis; Chromosome aberrations; Cytogenetics; DNA damage; Hormesis; Linear; Micronuclei; No threshold; Radon

Indexed keywords

HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; PROTEIN BCL 2; PROTEIN P53; RADON; RADON 222; URANIUM;

CANCER RISK; CARCINOGENICITY; CHEMICAL ANALYSIS; CHROMOSOME ABERRATION; CONCENTRATION (PARAMETERS); CYTOTOXICITY; DOSIMETRY; ENVIRONMENTAL FACTOR; GENE; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; HEALTH HAZARD; HEREDITY; HUMAN; HYPOXANTHINE PHOSPHORIBOSYL TRANSFERASE GENE; LUNG CANCER; MICRONUCLEUS; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; PROTO ONCOGENE; RADIATION EXPOSURE; RADIOACTIVITY; RADIOSENSITIVITY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; TUMOR SUPPRESSOR GENE;

CHROMOSOME ABERRATIONS; DNA DAMAGE; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; LUNG NEOPLASMS; MUTATION; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION, IONIZING; RADON; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84880153714     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140714024     Document Type: Review

References (249)

1. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). Report of the United Nations Scientific Committee on the Effects of Atomic Radiation to the General Assembly; United Nations: New York, NY, USA, 2000.
2. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). Biological Mechanisms of Radiation Actions at Low Doses. A white paper to guide the Scientific Committee's future programme of work; United Nations: New York, NY, USA, 2012.
3. Sachs, H.; Hernandez, T.; Ring, J. Regional geology and radon variability in buildings. Environ. Int. 1982, 8, 97-103.
4. Lubin, J. Lung cancer risk from residential radon: Meta-analysis of eight epidemiologic studies. J. Natl. Cancer 1997, 89, 49-57.
5. Pavia, M.; Bianco, A.; Pileggi, C.; Angelillo, I.F. Meta-analysis of residential exposure to radon gas and lung cancer. Bull. World Health Organ. 2003, 81, 732-738.
6. Sethi, T.; El-Ghamry, M.; Kloecker, G. Radon and lung cancer. Clin. Adv. Hematol. Oncol. 2012, 10, 157-164.
7. Darby, S.; Hill, D.; Auvinen, A.; Barros-Dios, J.M.; Baysson, H.; Bochicchio, F.; Deo, H.; Falk, R.; Forastiere, F.; Hakama, M. et al. Radon in homes and risk of lung cancer: Collaborative analysis of individual data from 13 European case-control studies. Br. Med. J. 2005, 330, doi:10.1136/bmj.38308.477650.63.
8. Committee on Health Risks of Exposure to Radon, National Reseaerch Council. Health Effects of Exposure to Radon; The National Academies Press: Washington, DC, USA, 1999.
9. Krewski, D.; Lubin, J.H.; Zielinski, J.M.; Alavanja, M.; Catalan, V.S.; Field, R.W.; Klotz, J.B.; Letourneau, E.G.; Lynch, C.F.; Lyon, J.I. Residential radon and risk of lung cancer: A combined analysis of 7 North American case-control studies. Epidemiology 2005, 16, 137.
10. Al-Zoughool, M.; Krewski, D. Health effects of radon: A review of the literature. Int. J. Radiat. Biol. 2009, 85, 57-69.
11. Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation, National Research Council. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2; The National Academies Press: Washington, DC, USA, 2006.
12. Morawska, L.; Phillips, C. Attachment of radon progeny to cigarette smoke aerosol. Aerosol Sci. Technol. 1992, 17, 149-158.
13. Biermann, A.H.; Sawyer, S.R. Attachment of radon progeny to cigarette-smoke aerosols. Lawrence Livermore Natl. Lab. 1995, doi:10.2172/78555.
14. McLaughlin, J.; O'Byrne, F. The role of daughter product plateout in passive radon detection. Radiat. Prot. Dosim. 1984, 7, 115-119.
15. Porstendörfer, J. Behaviour of radon daughter products in indoor air. Radiat. Prot. Dosim. 1984, 7, 107-113.
16. Neman, R.; Hadler N J.C.; Iunes, P.J.; Paulo, S.R. On indoor radon daughters' plate-out on material surfaces. Radiat. Meas. 2005, 39, 653-655.
17. Richardson, R.; Eatough, J.; Henshaw, D. Dose to red bone marrow from natural radon and thoron exposure. Br. J. Radiol. 1991, 64, 608-624.
18. Steinhausler, F.; Hofmann, W.; Lettner, H. Thoron exposure of man: A negligible issue? Radiat. Prot. Dosim. 1994, 56, 127-131.
19. Tokonami, S. Why is Rn-220 (thoron) measurement important? Radiat. Prot. Dosim. 2010, 141, 335-339.
20. Akiba, S.; Tokonami, S.; Bochicchio, F.; McLaughlin, J.; Tommasino, L.; Harley, N. Thoron: Its metrology, health effects and implications for radon epidemiology: A summary of roundtable discussions. Radiat. Prot. Dosim. 2010, 141, 477-481.
21. Eatough, J.; Henshaw, D. Radon and thoron associated dose to the basal layer of the skin. Phys. Med. Biol. 1992, 37, 955-967.
22. Reeves, D.; Stuck, R. Clinical and experimental results with thorotrast. Medicine 1938, 17, 37-74.
23. Looney, W. An investigation of the late clinical findings following thorotrast (thorium dioxide) administration. J. Occup. Environ. Med. 1960, 83, 163-185.
24. Ishikawa, Y.; Mori, T.; Kato, Y.; Tsuchiya, E.; Machinami, R.; Sugano, H.; Kitagawa, T. Lung cancers associated with thorotrast exposure: High incidence of small-cell carcinoma and implications for estimation of radon risk. Int. J. Cancer 1992, 52, 570-574.
25. Spiethoff, A.; Wesch, H.; Wegener, K.; Klimisch, H. The effects of Thorotrast and quartz on the induction of lung tumors in rats. Health Phys. 1992, 63, 101-110.
26. Hofmann, W.; Hornik, S. Lung dosimetry for thorotrast patients: Implications for inhalation of radon progeny. Radiat. Res. 1999, 152, S93-S96.
27. Dos Santos Silva, I.; Malveiro, F.; Jones, M.; Swerdlow, A. Mortality after radiological investigation with radioactive Thorotrast: A follow-up study of up to fifty years in Portugal. Radiat. Res. 2003, 159, 521-534.
28. Wang, L.; Liu, D.; Shimizu, T.; Fukumoto, M. Mechanisms of liver carcinogenesis by chronic exposure to alpha-particles form internally deposited Thorotrast. Int. Congr. Ser. 2005, 1276, 192-194.
29. Kendall, G.M.; Smith, T.J. Doses to organs and tissues from radon and its decay products. J. Radiol. Prot. 2002, 22, 389.
30. Axelson, O. Cancer risks from exposure to radon in homes. Environ. Health Perspect. 1995, 103, 37-43.
31. Deshpande, A.; Goodwin, E.; Bailey, S.; Marrone, B.; Lehnert, B. Alpha-particle-induced sister chromatid exchange in normal human lung fibroblasts: Evidence for an extranuclear target. Radiat. Res. 1996, 145, 260-267.
32. Lehnert, B.; Goodwin, E. Extracellular factor(s) following exposure to α particles can cause sister chromatid exchanges in normal human cells. Cancer Res. 1997, 57, 2164-2171.
33. Madas, B.G.; Balásházy, I. Mutation induction by inhaled radon progeny modeled at the tissue level. Radiat. Environ. Biophys. 2011, 50, 553-570.
34. Balásházy, I.; Farkas, A.; Madas, B.G.; Hofmann, W. Non-linear relationship of cell hit and transformation probabilities in a low dose of inhaled radon progenies. J. Radiol. Prot. 2009, 29, 147-162.
35. Farkas, A.; Hofmann, W.; Balásházy, I.; Szoke, I.; Madas, B.G.; Moustafa, M. Effect of site-specific bronchial radon progeny deposition on the spatial and temporal distributions of cellular responses. Radiat. Environ. Biophys. 2011, 50, 281-297.
36. Konishi, E.; Yoshizawa, Y. Estimation of depth of basal cell layer of skin for radiation protection. Radiat. Prot. Dosim. 1985, 11, 29-33.
37. Eatough, J.P. Alpha-particle dosimetry for the basal layer of the skin and the radon progeny 218-Po and 214-Po. Phys. Med. Biol. 1997, 42, 1899-1911.
38. Charles, M. Radon exposure of the skin: I. Biological effects. J. Radiol. Prot. 2007, 27, 231-252.
39. Etherington, D.; Pheby, D.; Bray, F. An ecological study of cancer incidence and radon levels in South West England. Eur. J. Cancer 1996, 32A, 1189-1197.
40. Wheeler, B.; Allen, J.; Depledge, M.; Curnow, A. Radon and skin cancer in Southwest England: An ecologic study. Epidemiology 2012, 23, 44-52.
41. Henshaw, D.; Eatough, J.; Richardson, R. Radon as a causative factor in induction of myeloid leukaemia and other cancers. Lancet 1990, 335, 1008-1012.
42. Kadhim, M.A.; Lorimore, S.A.; Goodhead, D.T.; Wright, E.G.; Hepburn, M.D.; Buckle, V.J. Alpha-particle-induced chromosomal instability in human bone marrow cells. Lancet 1994, 344, 987-988.
43. Wilkinson, G. Gastric cancer in New Mexico counties with significant deposits of uranium. Arch. Environ. Health 1985, 40, 307-312.
44. Kjellberg, S.; Wiseman, J. The relationship of radon to gastrointestinal malignancies. Am. Surg. 1995, 61, 822-825.
45. Darby, S.C.; Whitley, E.; Howe, G.R.; Hutchings, S.J.; Kusiak, R.A.; Lubin, J.H.; Morrison, H.I.; Tirmarche, M.; Tomasek, L.; Radford, E. et al. Radon and cancers other than lung-cancer in underground miners: A collaborative analysis of 11 studies. J. Natl. Cancer Inst. 1995, 87, 378-384.
46. Auvinen, A.; Salonen, L.; Pekkanen, J.; Pukkala, E.; Ilus, T.; Kurttio, P. Radon and other natural radionuclides in drinking water and risk of stomach cancer: A case-cohort study in Finland. Int. J. Cancer 2005, 114, 109-113.
47. Chen, D.J.; Strniste, G.F.; Tokita, N. The genotoxicity of alpha particles in human embryonic skin fibroblasts. Radiat. Res. 1984, 100, 321-327.
48. Narayanan, P.K.; Goodwin, E.H.; Lehnert, B.E. Alpha particles initiate biological production of superoxide anions and hydrogen peroxide in human cells. Cancer Res. 1997, 57, 3963-3971.
49. Fleischer, R.; Meyer, N.; Hadley, S.; MacDonald, J.; Cavallo, A. Personal radon dosimetry from eyeglass lenses. Radiat. Prot. Dosim. 2001, 97, 251-258.
50. Bigu, J.; Raz, R. Passive radon/thoron personal dosimeter using an electrostatic collector and a diffused-junction detector. Rev. Sci. Instrum. 1985, 56, 146.
51. Eatough, J.; Worley, A.; Moss, G. Personal monitoring of 218Po and 214Po radionuclide deposition onto individuals under normal environmental exposure conditions. Phys. Med. Biol. 1999, 44, 2227-2239.
52. Erickson, B. The therapeutic use of radon: A biomedical treatment in Europe; an "alternative" remedy in the United States. Dose-Response 2007, 5, 48-62.
53. Steinhäusler, F. Radon spas: Source term, doses and risk assessment. Radiat. Prot. Dosim. 1988, 24, 257-259.
54. Franke, A.; Reiner, L.; Pratzel, H.; Franke, T.; Resch, K. Long-term efficacy of radon spa therapy in rheumatoid arthritis-a randomized, sham-controlled study and follow-up. Rheumatology 2000, 39, 894-902.
55. U.S. Environmental Protection Agency Office of Radiation and Indoor Air. EPA assessment of risks from radon in homes; United States Environmental Protection Agency: Washington, DC, USA, 2003.
56. Wazer, D.E.; Chu, Q.; Liu, X.L.; Gao, Q.; Safaii, H.; Band, V. Loss of p53 protein during radiation transformation of primary human mammary epithelial cells. Mol. Cell. Biol. 1994, 14, 2468-2478.
57. Vähäkangas, K.H.; Bennett, W.P.; Castrén, K.; Welsh, J.A; Khan, M.A; Blömeke, B.; Alavanja, M.C.; Harris, C.C. p53 and K-ras mutations in lung cancers from former and never-smoking women. Cancer Res. 2001, 61, 4350-4356.
58. Hainaut, P.; Pfeifer, G.P. Patterns of p53 G→T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinogenesis 2001, 22, 367-374.
59. Toh, C.; Lim, W. Lung cancer in never-smokers. J. Clin. Pathol. 2007, 60, 337-340.
60. Vähäkangas, K.H.; Samet, J.M.; Metcalf, R.A.; Welsh, J.A.; Bennett, W.P.; Lane, D.P.; Harris, C.C. Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet 1992, 339, 576-580.
61. Hollstein, M.; Sidransky, D.; Vogelstein, B.; Harris, C.C. p53 mutations in human cancers. Science 1991, 253, 49-53.
62. Taylor, J.; Watson, M.; Michels, R.; Saccomanno, G.; Anderson, M. p53 mutation hotspot in radon-associated lung cancer. Lancet 1994, 343, 86-87.
63. McDonald, J.W.; Taylor, J.A; Watson, M.A; Saccomanno, G.; Devereux, T.R. p53 and K-ras in radon-associated lung adenocarcinoma. Cancer Epidemiol. Biomarkers Prev. 1995, 4, 791-793.
64. Wesch, H.; Wiethege, T.; Spiethoff, A.; Wegener, K.; Müller, K.M.; Mehlhorn, J. German uranium miner study: Historical background and available histopathological material. Radiat. Res. 1999, 152, S48-S51.
65. Hollstein, M.; Bartsch, H.; Wesch, H.; Kure, E.; Mustonen, R.; Muhlbauer, K.; Spiethoff, A.; Wegener, K.; Wiethege, T.; Muller, K. p53 gene mutation analysis in tumors of patients exposed to alpha-particles. Carcinogenesis 1997, 18, 511-516.
66. Wiethege, T.; Wesch, H.; Wegener, K.; Muller, K.; Mehlhorn, J.; Spiethoff, A.; Schomig, D.; Hollstein, M.; Bartsch, H. German uranium miner study: Pathological and molecular genetic findings. J. Radiat. Res. 1999, 152, S52-S55.
67. Yang, Q.; Wesch, H.; Mueller, K.M.; Bartsch, H.; Wegener, K.; Hollstein, M. Analysis of radon-associated squamous cell carcinomas of the lung for a p53 gene hotspot mutation. Br. J. Cancer 2000, 82, 763-766.
68. Popp, W.; Vahrenholz, C.; Schuster, H.; Wiesner, B.; Bauer, P.; Täuscher, F.; Plogmann, H.; Morgenroth, K.; Konietzko, N.; Norpoth, K. P53 mutations and codon 213 polymorphism of p53 in lung cancers of former uranium miners. J. Cancer Res. Clin. Oncol. 1999, 125, 309-312.
69. Hussain, S.P.; Kennedy, C.H.; Amstad, P.; Lui, H.; Lechner, J.F.; Harris, C.C. Radon and lung carcinogenesis: Mutability of p53 codons 249 and 250 to 238Pu alpha-particles in human bronchial epithelial cells. Carcinogenesis 1997, 18, 121-125.
70. Yngveson, A.; Williams, C.; Hjerpe, A.; Söderkvist, P.; Pershagen, G. p53 mutations in lung cancer associated with residential radon exposure. Cancer Epidemiol. 1999, 8, 433-438.
71. Ruano-Ravina, A.; Pérez-Becerra, R.; Fraga, M.; Kelsey, K.; Barros-Dios, J. Analysis of the relationship between p53 immunohistochemical expression and risk factors for lung cancer, with special emphasis on residential radon exposure. Ann. Oncol. 2008, 19, 109-114.
72. Lo, Y.; Darby, S.; Noakes, L.; Whitley, E.; Silcocks, P.; Fleming, K.; Bell, J. Screening for codon 249 p53 mutation in lung cancer associated with domestic radon exposure. Lancet 1995, 345, 60.
73. Venitt, S.; Biggs, P.J. Radon, mycotoxins, p53, and uranium mining. Lancet 1994, 343, 795.
74. Alavanja, M.; Brownson, R.; Lubin, J.; Berger, E.; Chang, J.; Boice, J.D. Residential radon exposure and lung cancer among nonsmoking women. J. Natl. Cancer Inst. 1994, 86, 1829-1837.
75. Johnson, N.; Carpenter, T.; Jaramillo, R.; Liberati, T. DNA damage-inducible genes as biomarkers for exposures to environmental agents. Environ. Health Perspect. 1997, 105, 913-918.
76. Li, H.; Gu, Y.; Miki, J.; Hukku, B.; McLeod, D.G.; Hei, T.K.; Rhim, J.S. Malignant transformation of human benign prostate epithelial cells by high linear energy transfer alpha-particles. Int. J. Oncol. 2007, 31, 537-544.
77. Gu, Y.; Li, H.; Miki, J.; Kim, K.-H.; Furusato, B.; Sesterhenn, I.A.; Chu, W.-S.; McLeod, D.G.; Srivastava, S.; Ewing, C.M. et al. Phenotypic characterization of telomerase-immortalized primary non-malignant and malignant tumor-derived human prostate epithelial cell lines. Exp. Cell Res. 2006, 312, 831-843.
78. Belinsky, S.A.; Swafford, D.S.; Finch, G.L.; Mitchell, C.E.; Kelly, G.; Hahn, F.F.; Anderson, M.W.; Nikula, K.J. Alterations in the K-ras and p53 genes in rat lung tumors. Environ. Health Perspect. 1997, 105, 901-906.
79. Bastide, K.; Guilly, M.-N.; Bernaudin, J.-F.; Joubert, C.; Lectard, B.; Levalois, C.; Malfoy, B.; Chevillard, S. Molecular analysis of the Ink4a/Rb1-Arf/Tp53 pathways in radon-induced rat lung tumors. Lung Cancer 2009, 63, 348-353.
80. Stout, J.T.; Caskey, C.T. HPRT: Gene structure, expression, and mutation. Ann. Rev. Genet. 1985, 19, 127-148.
81. Lesch, M.; Nyhan, W.L. A familial disorder of uric acid metabolism and central nervous system function. Am. J. Med. 1964, 36, 561-570.
82. Edwards, A.; Voss, H.; Rice, P.; Civitello, A.; Stegemann, J.; Schwager, C.; Zimmermann, J.; Erfle, H.; Caskey, C.; Ansorge, W. Automated DNA sequencing of the human HPRT locus. Genomics 1990, 6, 593-608.
83. Cariello, N.F.; Craft, T.R.; Vrieling, H.; van Zeeland, A.A.; Adams, T.; Skopek, T.R. Human HPRT mutant database: Software for data entry and retrieval. Environ. Mol. Mutagenes. 1992, 20, 81-83.
84. Cariello, N. Database and software for the analysis of mutations at the human hprt gene. Nucleic Acids Res. 1994, 22, 3547-3548.
85. Cariello, N.; Douglas, G.; Gorelick, N.; Hart, D.; Wilson, J.; Soussi, T. Databases and software for the analysis of mutations in the human p53 gene, human hprt gene and both the lacI and lacZ gene in transgenic rodents. Nucleic Acids Res. 1998, 26, 198-199.
86. Hakoda, M.; Hirai, Y.; Kyoizumi, S.; Akiyama, M. Molecular analyses of in vivo hprt mutant T cells from atomic bomb survivors. Environ. Mol. Mutagenes. 1989, 13, 25-33.
87. Hakoda, M.; Akiyama, M.; Kyoizumi, S.; Awa, A.; Yamakido, M.; Otake, M. Increased somatic cell mutant frequency in atomic bomb survivors. Mutat. Res. 1988, 201, 39-48.
88. Zwingmann, I.; Welle, I.; Engelen, J.; Schilderman, P.; de Jong, J.; Kleinjans, J. Analysis of oxidative DNA damage and HPRT mutant frequencies in cancer patients before and after radiotherapy. Mutat. Res. 1999, 431, 361-369.
89. Jinnah, H.; de Gregorio, L.; Harris, J.; Nyhan, W.; O'Neill, J. The spectrum of inherited mutations causing HPRT deficiency: 75 new cases and a review of 196 previously reported cases. Mutat. Res. 2000, 463, 309-326.
90. Shanahan, E.M.; Peterson, D.; Roxby, D.; Quintana, J.; Morely, A.A.; Woodward, A. Mutation rates at the glycophorin A and HPRT loci in uranium miners exposed to radon progeny. Occup. Environ. Med. 1996, 53, 439-444.
91. Woodward, A.; Roder, D.; McMichael, A.J.; Crouch, P.; Mylvaganam, A. Radon daughter exposures at the Radium Hill uranium mine and lung cancer rates among former workers, 1952-87. Cancer Causes Control 1991, 2, 213-220.
92. Bridges, B.; Cole, J.; Arlett, C.; Green, M.; Waugh, A.; Beare, D.; Henshaw, D.; Last, R. Possible association between mutant frequency in peripheral lymphocytes and domestic radon concentrations. Lancet 1991, 337, 1187-1189.
93. Yunis, J.J.; Oken, M.M.; Kaplan, M.E.; Ensrud, K.M.; Howe, R.R.; Theologides, A. Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. N. Engl. J. Med. 1982, 307, 1231-1236.
94. Gribben, J.; Freedman, A.; Woo, S.; Blake, K.; Shu, R.; Freeman, G.; Longtine, J.; Pinkus, G.; Nadler, L. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement. Blood 1991, 78, 3275-3280.
95. Cory, S.; Huang, D.; Adams, J. The Bcl-2 family: Roles in cell survival and oncogenesis. Oncogene 2003, 22, 8590-8607.
96. Cole, J.; Green, M.; Bridges, B.; Waugh, A.; Beare, D.; Henshaw, D.; Last, R.; Liu, Y.; Cortopassi, G. Lack of evidence for an association between the frequency of mutants or translocations in circulating lymphocytes and exposure to radon gas in the home. Radiat. Res. 1996, 145, 61-69.
97. Liu, Y.; Cortopassi, G.; Steingrimsdottir, H.; Waugh, A.P.; Beare, D.M.; Green, M.H.; Robinson, D.R.; Cole, J. Correlated mutagenesis of bcl2 and hprt loci in blood lymphocytes. Environ. Mol. Mutagenes. 1997, 29, 36-45.
98. Liu, Y.; Hernandez, A.; Shibata, D.; Cortopassi, G. BCL2 translocation frequency rises with age in humans. Proc. Natl. Acad. Sci. USA 1994, 91, 8910-8914.
99. Curry, J.; Karnaoukhova, L.; Guenette, G.; Glickman, B. Influence of sex, smoking and age on human hprt mutation frequencies and spectra. Genetics 1999, 152, 1065-1077.
100. Bell, D.; Liu, Y.; Cortopassi, G. Occurrence of bcl-2 oncogene translocation with increased frequency in the peripheral blood of heavy smokers. J. Natl. Cancer Inst. 1995, 87, 223-224.
101. Albering, H.J.; Hageman, G.J.; Kleinjans, J.C.; Engelen, J.J.; Koulishcer, L.; Herens, C. Indoor radon exposure and cytogenetic damage. Lancet 1992, 340, 739.
102. Albering, H.; Engelen, J.; Koulischer, L.; Welle, I.; Kleinjans, J. Indoor radon, an extrapulmonary genetic risk? Lancet 1994, 344, 750-751.
103. Ruttenber, A.; Harrison, L.; Baron, A.; McClure, D.; Glanz, J.; Quillin, R.; O'Neill, J.; Sullivan, L.; Campbell, J.; Nicklas, J. Hprt mutant frequencies, nonpulmonary malignancies, and domestic radon exposure: "Postmortem" analysis of an interesting hypothesis. Environ. Mol. Mutagenes. 2001, 37, 7-16.
104. Zwingmann, I.; Welle, I.; van Herwijnen, M.; Engelen, J.; Schilderman, P.; Smid, T.; Kleinjans, J. Oxidative DNA damage and cytogenetic effects in flight engineers exposed to cosmic radiation. Environ. Mol. Mutagenes. 1998, 32, 121-129.
105. Seifert, A.; Demers, C.; Dubeau, H.; Messing, K. HPRT-mutant frequency and lymphocyte characteristics of workers exposed to ionizing radiation on a sporadic basis: A comparison of two exposure indicators, job title and dose. Mutat. Res. 1993, 319, 61-70.
106. McDiarmid, M.; Albertini, R.; Tucker, J.; Vacek, P.; Carter, E.; Bakhmutsky, M.; Oliver, M.; Engelhardt, S.; Squibb, K. Measures of genotoxicity in Gulf war I veterans exposed to depleted uranium. Environ. Mol. Mutagenes. 2011, 52, 569-581.
107. Xie, H.; LaCerte, C.; Thompson, W.; Wise, J. Depleted uranium induces neoplastic transformation in human lung epithelial cells. Chem. Res. Toxicol. 2010, 23, 373-378.
108. Wise, S.S.; Thompson, W.D.; Aboueissa, A.-M.; Mason, M.D.; Wise, J.P. Particulate depleted uranium is cytotoxic and clastogenic to human lung cells. Chem. Res. Toxicol. 2007, 20, 815-820.
109. Cui, F.; Fan, S.; Hu, M.; Nie, J.; Li, H.; Tong, J. Micronuclei rate and hypoxanthine phosphoribosyl transferase mutation in radon-exposed rats. Prog. Nat. Sci. 2008, 18, 1305-1308.
110. Jostes, R.F.; Fleck, E.W.; Morgan, T.L.; Stiegler, G.L.; Cross, F.T. Southern blot and polymerase chain reaction exon analyses of HPRT-mutations induced by radon and radon progeny. Radiat. Res. 1994, 137, 371-379.
111. Jostes, R.; Hui, T.; James, A.; Cross, F.; Schwartz, J.; Rotmensch, J.; Atcher, R.; Evans, H.; Mencl, J.; Bakale, G. et al. In vitro exposure of mammalian cells to radon: Dosimetric considerations. Radiat. Res. 1991, 127, 211-219.
112. Kiefer, J.; Schreiber, A.; Gutermuth, F.; Koch, S.; Schmidt, P. Mutation induction by different types of radiation at the Hprt locus. Mutat. Res. 1999, 431, 429-448.
113. Bao, C.Y.; Ma, A.; Evans, H.H.; Horng, M.F.; Mencl, J.; Hui, T.E.; Sedwick, W.D. Molecular analysis of hypoxanthine phosphoribosyltransferase gene deletions induced by alpha-and X-radiation in human lymphoblastoid cells. Mutat. Res. 1994, 326, 1-15.
114. Bakale, G.; Rao, P.S.; Mencl, J.; Adams, R.B.; Evans, H.H. A radon generator/delivery system. Radiat. Res. 1993, 133, 277-281.
115. Chaudhry, M.; Jiang, Q.; Ricanati, M.; Horng, M.; Evans, H. Characterization of multilocus lesions in human cells exposed to X radiation and radon. Radiat. Res. 1996, 145, 31-38.
116. Amundson, S.; Chen, D.; Okinaka, R. Alpha particle mutagenesis of human lymphoblastoid cell lines. Int. J. Radiat. Biol. 1996, 70, 219-226.
117. Hsie, A.; Porter, R.; Xu, Z.; Yu, Y.; Sun, J.; Meltz, M.; Schwartz, J. Molecular markers of ionizing radiation-induced gene mutations in mammalian cells. Environ. Health Perspect. 1996, 104, 675-678.
118. Schwartz, J.; Hsie, A. Genetic and cytogenetic markers of exposure to high-linear energy transfer radiation. Radiat. Res. 1997, 148, S87-S92.
119. Albertini, R.; Clark, L.; Nicklas, J.; O'Neill, J.; Hui, T.; Jostes, R. Radiation quality affects the efficiency of induction and the molecular spectrum of HPRT mutations in human T cells. Radiat. Res. 1997, 148, S76-S86.
120. O'Neill, P.; Nicklas, J.; Hirsch, B.; Jostes, R.; Hunter, T.; Sullivan, L.; Albertini, R. In vitro studies of the genotoxicity of ionizing radiation in human G(0) T lymphocytes. Environ. Mol. Mutagenes. 2005, 46, 207-220.
121. Schwartz, J.L.; Jordan, R.; Sun, J.; Ma, H.; Hsieb, A. Dose-dependent changes in the spectrum of mutations induced by ionizing radiation. Radiat. Res. 2000, 153, 312-317.
122. Nagasawa, H.; Little, J. Unexpected sensitivity to the induction of mutations by very low doses of alpha-particle radiation: Evidence for a bystander effect. Radiat. Res. 1999, 152, 552-557.
123. Huo, L.; Nagasawa, H.; Little, J. HPRT mutants induced in bystander cells by very low fluencies of alpha particles result primarily from point mutations. Radiat. Res. 2001, 156, 521-525.
124. Nagasawa, H.; Huo, L.; Little, J.B. Increased bystander mutagenic effect in DNA double-strand break repair-deficient mammalian cells. Int. J. Radiat. Biol. 2003, 79, 35-41.
125. Da Cruz, A.; Curry, J.; Curado, M.; Glickman, B. Monitoring hprt mutant frequency over time in T-lymphocytes of people accidentally exposed to high doses of ionizing radiation. Environ. Mol. Mutagenes. 1996, 27, 165-175.
126. Mitelman, F. Catalog of chromosome aberrations in cancer, 4th edition, in two parts. Am. J. Hum. Genet. 1992, 50, 1354-1355.
127. Solomon, E.; Borrow, J.; Goddard, A.D. Chromosome aberrations and cancer. Science 1991, 254, 1153-1160.
128. Albertson, D.G.; Collins, C.; McCormick, F.; Gray, J.W. Chromosome aberrations in solid tumors. Nat. Genet. 2003, 34, 369-376.
129. Bender, M.; Griggs, H.; Bedford, J. Mechanisms of chromosomal aberration production III. Chemicals and ionizing radiation. Mutat. Res. 1974, 23, 197-212.
130. Sorsa, M.; Wilbourn, J.; Vainio, H. Human cytogenetic damage as a predictor of cancer risk. IARC Sci. Publ. 1992, 543-554.
131. Norppa, H. Cytogenetic biomarkers and genetic polymorphisms. Toxicol. Lett. 2004, 149, 309-334.
132. Tucker, J.D.; Auletta, A.; Cimino, M.C.; Dearfield, K.L.; Jacobson-Kram, D.; Tice, R.R.; Carrano, A.V. Sister-chromatid exchange: Second report of the Gene-Tox program. Mutat. Res. 1993, 297, 101-180.
133. Anderson, B.E.; Zeiger, E.; Shelby, M.D.; Resnick, M.A.; Gulati, D.K.; Ivett, J.L.; Loveday, K.S. Chromosome aberration and sister chromatid exchange test results with 42 chemicals. Environ. Mol. Mutagenes. 1990, 16, 55-137.
134. Galloway, S.M.; Armstrong, M.J.; Reuben, C.; Colman, S.; Brown, B.; Cannon, C.; Bloom, A.D.; Nakamura, F.; Ahmed, M.; Duk, S. Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: Evaluations of 108 chemicals. Environ. Mol. Mutagenes. 1987, 10, 1-35.
135. Wald, N.; Koizumi, A.; Pan, S. A pilot study of the relationship between chromosome aberrations and occupational external and internal radiation exposure. Hum. Radiat. Cytogenet. 1968, 183-193.
136. Boyd, J.; Brown, W.; Vennart, J.; Woodcock, G. Chromosome studies on women formerly employed as luminous-dial painters. Br. Med. J. 1966, 1, 377-382.
137. Sax, K. Chromosome aberrations induced by X-rays. Genetics 1938, 23, 494-516.
138. Brown, J.; McNeill, J. Aberrations in leukocyte chromosomes of personnel occupationally exposed to low levels of radiation. Radiat. Res. 1969, 40, 534-543.
139. Ishihara, T.; Kumatori, T. Chromosome studies on japanese exposed to radiation resulting from nuclear bomb explosions. Hum. Radiat. Cytogenet. 1968, 144-166.
140. Awa, A.; Honda, T.; Sofuni, T.; Neriishi, S. Chromosome-aberration frequency in cultured blood-cells in relation to radiation dose of A-bomb survivors. Lancet 1971, 298, 903-905.
141. Müller, I.; Geinitz, H.; Braselmann, H.; Baumgartner, A.; Fasan, A.; Thamm, R.; Molls, M.; Meineke, V.; Zitzelsberger, H. Time-course of radiation-induced chromosomal aberrations in tumor patients after radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2005, 63, 1214-1220.
142. Jones, L.A.; Scott, D.; Cowan, R.; Roberts, S.A. Abnormal radiosensitivity of lymphocytes from breast cancer patients with excessive normal tissue damage after radiotherapy: Chromosome aberrations after low dose-rate irradiation. Int. J. Radiat. Biol. 1995, 67, 519-528.
143. Barrios, L.; Miró, R.; Caballín, M.R.; Fuster, C.; Guedea, F.; Subias, A.; Egozcue, J. Cytogenetic effects of radiotherapy. Breakpoint distribution in induced chromosome aberrations. Cancer Genet. Cytogenet. 1989, 41, 61-70.
144. AlSuhaibani, E.S. Chromosomal aberration analysis among underground water well workers in Saudi Arabia. Radiat. Prot. Dosim. 2011, 144, 651-654.
145. 60Co radiation. Br. J. Radiol. 2009, 82, 1027-1032.
146. 60Co radiation. Health Phys. 2010, 98, 885-888.
147. Heimers, A.; Brede, H.J.; Giesen, U.; Hoffmann, W. Chromosome aberration analysis and the influence of mitotic delay after simulated partial-body exposure with high doses of sparsely and densely ionising radiation. Radiat. Environ. Biophys. 2006, 45, 45-54.
148. Savage, J. Classification and relationships of induced chromosomal structual changes. J. Med. Genet. 1976, 12, 103-122.
149. Shadley, J.; Whitlock, J.; Rotmensch, J.; Atcher, R.; Tang, J.; Schwartz, J. The effects of radon daughter alpha-particle irradiation in K1 and xrs-5 CHO cell lines. Mutat. Res. 1991, 248, 73-83.
150. Wolff, S.; Jostes, R.; Cross, F.T.; Hui, T.E.; Afzal, V.; Wiencke, J.K. Adaptive response of human lymphocytes for the repair of radon-induced chromosomal damage. Mutat. Res. 1991, 250, 299-306.
151. Kadhim, M.; Macdonald, D.; Goodhead, D.; Lorimore, S.; Marsden, S.; Wright, E. Transmission of chromosomal instability after plutonium alpha-particle irradiation. Nature 1992, 355, 738-740.
152. Nagasawa, H.; Robertson, J.; Little, J. Induction of chromosomal aberrations and sister chromatid exchanges by alpha particles in density-inhibited cultures of mouse 10T1/2 and 3T3 cells. Int. J. Radiat. Biol. 1990, 57, 35-44.
153. Nagasawa, H.; Little, J.B. Induction of sister chromatid exchanges by extremely low doses of α-particles. Cancer Res. 1992, 52, 6394-6396.
154. Iyer, R.; Lehnert, B.E.; Svensson, R. Factors underlying the cell growth-related bystander responses to α particles. Cancer Res. 2000, 60, 1290-1298.
155. Azzam, E.; de Toledo, S.; Gooding, T.; Little, J. Intercellular communication is involved in the bystander regulation of gene expression in human cells exposed to very low fluences of alpha particles. Radiat. Res. 1998, 150, 497-504.
156. Pohl-Rüling, J.; Lettner, H.; Hofmann, W.; Eckl, P.; Haas, O.; Obe, G.; Grell-Büchtmann, I.; van Buul, P.; Schroeder-Kurth, T.; Atzmüller, C. et al. Chromosomal aberrations of blood lymphocytes induced in vitro by radon-222 daughter alpha irradiation. Mutat. Res. 2000, 449, 7-19.
157. Hamza, V.Z.; Mohankumar, M.N. Cytogenetic damage in human blood lymphocytes exposed in vitro to radon. Mutat. Res. 2009, 661, 1-9.
158. Meenakshi, C.; Mohankumar, M. Radon-induced chromosome damage in blood lymphocytes of smokers. Res. J. Environ. Toxicol. 2012, 6, 51-58.
159. Costa-Ribeiro, C.; Barcinski, M.A.; Figueiredo, N.; Franca, E.P.; Lobão, N. Radiobiological aspects and radiation levels associated with the milling of monazite sand. Health Phys. 1975, 28, 225-231.
160. Livingston, G.K.; Falk, R.B.; Schmid, E. Effect of occupational radiation exposures on chromosome aberration workers rates in former plutonium workers. Radiat. Res. 2006, 166, 89-97.
161. Smerhovsky, Z.; Landa, K.; Rössner, P.; Brabec, M.; Zudova, Z.; Hola, N.; Pokorna, Z.; Mareckova, J.; Hurychova, D. Risk of cancer in an occupationally exposed cohort with increased level of chromosomal aberrations. Environ. Health Perspect. 2001, 109, 41-45.
162. Smerhovsky, Z.; Landa, K.; Rössner, P.; Juzova, D.; Brabec, M.; Zudova, Z.; Hola, N.; Zarska, H.; Nevsimalova, E. Increased risk of cancer in radon-exposed miners with elevated frequency of chromosomal aberrations. Mutat. Res. 2002, 514, 165-176.
163. Brandom, W.F.; Saccomanno, G.; Archer, V.E.; Archer, P.G.; Coors, M.E. Chromosome aberrations in uranium miners occupationally exposed to 222 Radon. Radiat. Res. 1972, 52, 204-215.
164. Brandom, W.F.; Saccomanno, G.; Archer, V.E.; Archer, P.G.; Bloom, A.D. Chromosome aberrations as a biological dose-response indicator of radiation exposure in uranium miners. Radiat. Res. 1978, 76, 159-171.
165. Bilban, M. Influence of the work environment in a Pb-Zn mine on the incidence of cytogenetic damage in miners. Am. J. Ind. Med. 1998, 34, 455-463.
166. Bilban, M.; Jakopin, C. Incidence of cytogenetic damage in lead-zinc mine workers exposed to radon. Mutagenesis 2005, 20, 187-191.
167. Popp, W.; Plappert, U.; Müller, W.U.; Rehn, B.; Schneider, J.; Braun, A.; Bauer, P.C.; Vahrenholz, C.; Presek, P.; Brauksiepe, A. et al. Biomarkers of genetic damage and inflammation in blood and bronchoalveolar lavage fluid among former German uranium miners: A pilot study. Radiat. Environ. Biophys. 2000, 39, 275-282.
168. Sram, R.; Binková, B. Monitoring genotoxic exposure in uranium miners. Environ. Health Perspect. 1993, 99, 303-305.
169. Zölzer, F.; Hon, Z.; Skalická, Z.F.; Havránková, R.; Navrátil, L.; Rosina, J.; Škopek, J. Micronuclei in lymphocytes from currently active uranium miners. Radiat. Environ. Biophys. 2012, 51, 277-282.
170. Zaire, R.; Notter, M.; Riedel, W.; Thiel, E. Unexpected rates of chromosomal instabilities and alterations of hormone levels in Namibian uranium miners. Radiat. Res. 1997, 147, 579-584.
171. Mészáros, G.; Bognár, G.; Köteles, G.J. Long-term persistence of chromosome aberrations in uranium miners. J. Occup. Health 2004, 46, 310-315.
172. Tawn, E.; Whitehouse, C.; Tarone, R. FISH chromosome aberration analysis on retired radiation workers from the Sellafield nuclear facility. Radiat. Res. 2004, 162, 249-256.
173. Barcinski, M.; do Céu Abreu, M.; de Almeida, J.; Naya, J.; Fonseca, L.; Castro, L. Cytogenetic investigation in a Brazilian population living in an area of high natural radioactivity. Am. J. Hum. Genet. 1975, 27, 802-806.
174. Pohl-Rüling, J.; Fischer, P. The dose-effect relationship of chromosome aberrations to α and γ irradiation in a population subjected to an increased burden of natural radioactivity. Radiat. Res. 1979, 80, 61-81.
175. Chen, D.; Wei, L. Chromosome aberration, cancer mortality and hormetic phenomena among inhabitants in areas of high background radiation in china. J. Radiat. Res. 1991, 32, 46-53.
176. Bauchinger, M.; Schmid, E.; Braselmann, H.; Kulka, U. Chromosome aberrations in peripheral lymphocytes from occupants of houses with elevated indoor radon concentrations. Mutat. Res. 1994, 310, 135-142.
177. Lindholm, C.; Mäkeläinen, I.; Paile, W.; Koivistoinen, A.; Salomaa, S. Domestic radon exposure and the frequency of stable or unstable chromosomal aberrations in lymphocytes. Int. J. Radiat. Biol. 1999, 75, 921-928.
178. Boffetta, P.; van der Hel, O.; Norppa, H.; Fabianova, E.; Fucic, A.; Gundy, S.; Lazutka, J.; Cebulska-Wasilewska, A.; Puskailerova, D.; Znaor, A. et al. Chromosomal aberrations and cancer risk: results of a cohort study from Central Europe. Am. J. Epidemiol. 2007, 165, 36-43.
179. Bilban, M.; Vaupoti, J. Chromosome aberrations study of pupils in high radon level elementary school. Health Phys. 2001, 80, 157-163.
180. Minina, V.I.; Druzhinin, V.G.; Golovina, T.A.; Larin, S.A.; Mun, S.A.; Akhmat'Ianova, V.R.; Bakanova, M.L.; Glushkov, A.N. Spread of carcinogenic and mutagenic effects in the population of Gornaia Shoria. Gig. Sanit. 2011, 35-38.
181. Druzhinin, V.G.; Akhmat'ianova, V.R.; Golovina, T.A.; Volkov, A.N.; Minina, V.I.; Larionov, A.V.; Makeeva, E.A. Genome sensitivity and genotoxic effects features in children-teenagers affected by radon radiation in living and educational environment. Radiats. Biol. Radioecol. 2009, 49, 568-573.
182. Minina, V.; Druzhinin, V.; Lunina, A.; Larionov, A.; Golovina, T.; Glushkov, A. Association of DNA repair gene polymorphism with chromosomal aberrations frequency in human lymphocytes. Russ. J. Genet. 2012, 2, 171-176.
183. Bilban, M.; Bilban-Jakopin, C.; Vrhovec, S. Incidence of chromosomal aberrations and micronuclei in cave tour guides. Neoplasma 2001, 48, 278-284.
184. Lehnert, B.; Goodwin, E. A new mechanism for DNA alterations induced by alpha particles such as those emitted by radon and radon progeny. Environ. Health Perspect. 1997, 105, 1095-1101.
185. Hamza, V.Z.; Kumar, P.R.V.; Jeevanram, R.K.; Santanam, R.; Danalaksmi, B.; Mohankumar, M.N. A simple method to irradiate blood cells in vitro with radon gas. Radiat. Prot. Dosim. 2008, 130, 343-350.
186. Bender, M.; Gooch, P. Persistent chromosome aberrations in irradiated human subjects. II. Three and one-half year investigation. Radiat. Res. 1963, 18, 389-396.
187. Awa, A. Persistent chromosome aberrations in the somatic cells of A-bomb survivors, Hiroshima and Nagasaki. Radiat. Res. 1991, 32, 265-274.
188. Bender, M.; Gooch, P. Persistent chromosome aberrations in irradiated human subjects. Radiat. Res. 1962, 16, 44-53.
189. Brenner, D.; Sachs, R. Chromosomal "fingerprints" of prior exposure to densely ionizing radiation. Radiat. Res. 1994, 140, 134-142.
190. Brenner, D.; Okladnikova, N.; Hande, P.; Burak, L.; Geard, C.; Azizova, T. Biomarkers specific to densely-ionising (high LET) radiations. Radiat. Prot. Dosim. 2001, 97, 69-73.
191. + cells. Radiat. Res. 2007, 167, 541-550.
192. Tawn, E.; Whitehouse, C. Chromosome intra-and inter-changes determined by G-banding in radiation workers with in vivo exposure to plutonium. J. Radiol. Prot. 2005, 25, 83-88.
193. Fenech, M.; Morley, A. Measurement of micronuclei in lymphocytes. Mutat. Res. 1985, 147, 29-36.
194. Heddle, J.A.; Carrano, A.V. The DNA content of micronuclei induced in mouse bone marrow by gamma-irradiation: Evidence that micronuclei arise from acentric chromosomal fragments. Mutat. Res. 1977, 44, 63-69.
195. Countryman, P.; Heddle, J. The production of micronuclei from chromosome aberrations in irradiated cultures of human lymphocytes. Mutat. Res. 1976, 41, 321-331.
196. Bonassi, S.; El-Zein, R.; Bolognesi, C.; Fenech, M. Micronuclei frequency in peripheral blood lymphocytes and cancer risk: Evidence from human studies. Mutagenesis 2011, 26, 93-100.
197. Khan, M.A.; Cross, F.T.; Jostes, R.; Hui, E.; Morris, J.E.; Brooks, A.L. Micronuclei induced by radon and its progeny in deep-lung fibroblasts of rats in vivo and in vitro. Radiat. Res. 1994, 139, 53-59.
198. Taya, A.; Morgan, A.; Baker, S.; Humphreys, J.; Bisson, M.; Collier, C. Changes in the rat lung after exposure to radon and its progeny: Effects on incorporation of bromodeoxyuridine in epithelial cells and on the incidence of nuclear aberrations in alveolar macrophages. Radiat. Res. 1994, 139, 170-177.
199. Nelson, J.; Brooks, A.; Metting, N.; Khan, M.; Buschbom, R.; Duncan, A.; Miick, R.; Braby, L. Clastogenic effects of defined numbers of 3.2 MeV alpha particles on individual CHO-K1 cells. Radiat. Res. 1996, 145, 568-574.
200. Hei, T.K.; Wu, L.J.; Liu, S.X.; Vannais, D.; Waldren, C.A; Randers-Pehrson, G. Mutagenic effects of a single and an exact number of alpha particles in mammalian cells. Proc. Natl. Acad. Sci. USA 1997, 94, 3765-3770.
201. Kennedy, C.H.; Mitchell, C.E.; Fukushima, N.H.; Neft, R.E.; Lechner, J.F. Induction of genomic instability in normal human bronchial epithelial cells by 238Pu alpha-particles. Carcinogenesis 1996, 17, 1671-1676.
202. Tobias, E.S.; Hurlstone, A.F.; MacKenzie, E.; McFarlane, R.; Black, D.M. The TES gene at 7q31.1 is methylated in tumours and encodes a novel growth-suppressing LIM domain protein. Oncogene 2001, 20, 2844-2853.
203. Chêne, L.; Giroud, C.; Desgrandchamps, F.; Boccon-Gibod, L.; Cussenot, O.; Berthon, P.; Latil, A. Extensive analysis of the 7q31 region in human prostate tumors supports TES as the best candidate tumor suppressor gene. Int. J. Cancer 2004, 111, 798-804.
204. Zenklusen, J.C.; Thompson, J.C.; Klein-szanto, A.J.P.; Conti, C.J. Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: Evidence for a broad range tumor suppressor gene. Cancer Res. 1995, 55, 1347-1350.
205. Ruas, M.; Peters, G. The p16 INK4a/CDKN2A tumor suppressor and its relatives. Biochim. Biophys. Acta 1998, 1378, F115-F177.
206. Belchior, A.; Gil, O.M.; Almeida, P.; Vaz, P. Evaluation of the cytotoxicity and the genotoxicity induced by α radiation in an A549 cell line. Radiat. Meas. 2011, 46, 958-961.
207. Chaudhry, M.A. Analysis of gene expression in normal and cancer cells exposed to gamma-radiation. J. Biomed. Biotechnol. 2008, 2008, 541678.
208. Chaudhry, M.; Omaruddin, R.; Kreger, B.; de Toledo, S.; Azzam, E. Micro RNA responses to chronic or acute exposures to low dose ionizing radiation. Mol. Biol. Rep. 2012, 39, 7549-7558.
209. Chaudhry, M.; Omaruddin, R. Differential regulation of MicroRNA expression in irradiated and bystander cells. Mol. Biol. 2012, 46, 569-578.
210. Chaudhry, M.; Omaruddin, R. Transcriptional changes of mitochondrial genes in irradiated cells proficient or deficient in p53. J. Genet. 2012, 91, 105-110.
211. Amundson, S.; do, K.; Shahab, S.; Bittner, M.; Meltzer, P.; Trent, J.; Fornace, A. Identification of potential mRNA biomarkers in peripheral blood lymphocytes for human exposure to ionizing radiation. Radiat. Res. 2000, 154, 342-346.
212. Scott, B.R.; Walker, D.M.; Tesfaigzi, Y.; Schöllnberger, H.; Walker, V. Mechanistic basis for nonlinear dose-response relationships for low-dose radiation-induced stochastic effects. Nonlinearity Biol. Toxicol. Med. 2003, 1, 93-122.
213. Feinendegen, L.E. Evidence for beneficial low level radiation effects and radiation hormesis. Br. J. Radiol. 2005, 78, 3-7.
214. Baskar, R. Emerging role of radiation induced bystander effects: Cell communications and carcinogenesis. Genome Integr. 2010, 1, 13.
215. Zhou, H.; Suzuki, M.; Randers-Pehrson, G.; Vannais, D.; Chen, G.; Trosko, J.E.; Waldren, C.A; Hei, T.K. Radiation risk to low fluences of alpha particles may be greater than we thought. Proc. Natl. Acad. Sci. USA 2001, 98, 14410-14415.
216. Little, M.P.; Wakeford, R. The bystander effect in experimental systems and compatibility with radon-induced lung cancer in humans. J. Radiol. Prot. 2002, 22, A27-A31.
217. Little, M.; Wakeford, R.; Tawn, E.; Bouffler, S.; de Gonzalez, A. Risks associated with low doses and low dose rates of ionizing radiation: Why linearity may be (almost) the best we can do. Radiology 2009, 251, 6-12.
218. Sawant, S.G.; Zheng, W.; Hopkins, K.M.; Randers-Pehrson, G.; Lieberman, H.B.; Hall, E.J. The radiation-induced bystander effect for clonogenic survival. Radiat. Res. 2002, 157, 361-364.
219. Goldberg, Z.; Lehnert, B.E. Radiation-induced effects in unirradiated cells: A review and implications in cancer. Int. J. Oncol. 2002, 21, 337-349.
220. Wu, L.J.; Randers-Pehrson, G.; Xu, A; Waldren, C.A.; Geard, C.R.; Yu, Z.; Hei, T.K. Targeted cytoplasmic irradiation with alpha particles induces mutations in mammalian cells. Proc. Natl. Acad. Sci. USA 1999, 96, 4959-4964.
221. Prise, K.; O'Sullivan, J. Radiation-induced bystander signalling in cancer therapy. Nature Rev. Cancer 2009, 9, 351-360.
222. Belyakov, O.V.; Mitchell, S.A.; Parikh, D.; Randers-Pehrson, G.; Marino, S.A.; Amundson, S.A.; Geard, C.R.; Brenner, D.J. Biological effects in unirradiated human tissue induced by radiation damage up to 1 mm away. Proc. Natl. Acad. Sci. USA 2005, 102, 14203-14208.
223. Chen, S.; Zhao, Y.; Han, W.; Chiu, S.K.; Zhu, L.; Wu, L.; Yu, K.N. Rescue effects in radiobiology: Unirradiated bystander cells assist irradiated cells through intercellular signal feedback. Mutat. Res. 2011, 706, 59-64.
224. Zhou, H.; Ivanov, V.N.; Gillespie, J.; Geard, C.R.; Amundson, S.A.; Brenner, D.J.; Yu, Z.; Lieberman, H.B.; Hei, T.K. Mechanism of radiation-induced bystander effect: Role of the cyclooxygenase-2 signaling pathway. Proc. Natl. Acad. Sci. USA 2005, 102, 14641-14646.
225. Nagasawa, H.; Cremesti, A.; Kolesnick, R.; Fuks, Z.; Little, J. Involvement of membrane signaling in the bystander effect in irradiated cells. Cancer Res. 2002, 62, 2531-2534.
226. Yu, H. Typical cell signaling response to ionizing radiation: DNA damage and extranuclear damage. Chin. J. Cancer Res. 2012, 24, 83-89.
227. Shao, C.; Folkard, M.; Michael, B.D.; Prise, K.M. Targeted cytoplasmic irradiation induces bystander responses. Proc. Natl. Acad. Sci. USA 2004, 101, 13495-13500.
228. Burdak-Rothkamm, S.; Short, S.C.; Folkard, M.; Rothkamm, K.; Prise, K.M. ATR-dependent radiation-induced gamma H2AX foci in bystander primary human astrocytes and glioma cells. Oncogene 2007, 26, 993-1002.
229. Schaue, D.; Kachikwu, E.L.; McBride, W.H. Cytokines in radiobiological responses: A review. Radiat. Res. 2012, 178, 505-523.
230. Hall, E.J. The bystander effect. Health Phys. 2003, 85, 31-35.
231. Morgan, W. Is there a common mechanism underlying genomic instability, bystander effects and other nontargeted effects of exposure to ionizing radiation? Oncogene 2003, 22, 7094-7099.
232. Morgan, W. Non-targeted and delayed effects of exposure to ionizing radiation: I. Radiation induced genomic instability and bystander effects in vitro. Radiat. Res. 2003, 159, 567-580.
233. Little, J.B. Radiation carcinogenesis. Carcinogenesis 2000, 21, 397-404.
234. Iyer, R.; Lehnert, B. Low dose, low-LET ionizing radiation-induced radioadaptation and associated early responses in unirradiated cells. Mutat. Res. 2002, 503, 1-9.
235. Matsumoto, H.; Hayashi, S.; Hatashita, M.; Ohnishi, K.; Shioura, H.; Ohtsubo, T.; Kitai, R.; Ohnishi, T.; Kano, E. Induction of radioresistance by a nitric oxide-mediated bystander effect. Radiat. Res. 2001, 155, 387-396.
236. Barcellos-Hoff, M.; Brooks, A. Extracellular signaling through the microenvironment: A hypothesis relating carcinogenesis, bystander effects, and genomic instability. Radiat. Res. 2001, 156, 618-627.
237. Wolff, S. The adaptive response in radiobiology: Evolving insights and implications. Environ. Health Perspect. 1998, 106, 277-283.
238. Bonner, W. Low-dose radiation: Thresholds, bystander effects, and adaptive responses. Proc. Natl. Acad. Sci. 2003, 100, 4973-4975.
239. Ghiassi-nejad, M.; Mortazavi, S.M.J.; Cameron, J.R.; Niroomand-rad, A; Karam, P.A Very high background radiation areas of Ramsar, Iran: Preliminary biological studies. Health phys. 2002, 82, 87-93.
240. Mothersill, C.; Seymour, C.B. Radiation-induced bystander effects and the DNA paradigm: An "out of field" perspective. Mutat. Res. 2006, 597, 5-10.
241. Forastiere, F.; Sperati, A.; Cherubini, G.; Miceli, M.; Biggeri, A.; Axelson, O. Adult myeloid leukaemia, geology, and domestic exposure to radon and gamma radiation: A case control study in central Italy. Occup. Environ. Med. 1998, 55, 106-110.
242. Rechavi, G.; Berkowicz, M.; Rosner, E.; Neuman, Y.; Ben-Bassat, I.; Ramot, B. Chromosomal aberrations suggestive of mutagen-related leukemia after 21 years of "therapeutic" radon exposure. Cancer Genet. Cytogenet. 1990, 48, 125-130.
243. Eatough, J.; Henshaw, D. Radon dose to the skin and the possible induction of skin cancers. Radiat. Prot. Dosim. 1991, 39, 33.
244. Attar, M.; Kondolousy, Y.; Khansari, N. Effect of high dose natural ionizing radiation on the immune system of the exposed residents of Ramsar Town, Iran. Iran J. Allergy Asthma 2007, 6, 73-78.
245. Chauhan, V.; Howland, M.; Kutzner, B.; McNamee, J.P.; Bellier, P.V.; Wilkins, R.C. Biological effects of alpha particle radiation exposure on human monocytic cells. Int. J. Hyg. Environ. Health 2012, 215, 339-344.
246. Jostes, R.F. Genetic, cytogenetic, and carcinogenic effects of radon: a review. Mutat. Res. 1996, 340, 125-139.
247. Leonard, B.E.; Thompson, R.E.; Beecher, G.C. Human lung cancer risks from radon-Part II-Influence from combined adaptive response and bystander effects-A microdose analysis. Dose-Response 2011, 9, 502-553.
248. Hall, E.J.; Hei, T.K. Genomic instability and bystander effects induced by high-LET radiation. Oncogene 2003, 22, 7034-7042.
249. Schöllnberger, H.; Mitchel, R.; Redpath, J.; Crawford-Brown, D.; Hofmann, W. Detrimental and protective bystander effects: A model approach. Radiat. Res. Soc. 2009, 168, 614-626.